Iris atrophy after administration of Dexycu: Additional evidence and possible mechanism for a rare complication

PURPOSE: To report the observation of iris atrophy with the use of Dexycu in cataract surgery and describe a possible mechanism for this complication. OBSERVATIONS: Between 2020 and 2021, 2 patients underwent cataract surgery procedures with the use of Dexycu and experienced iris atrophy. The first...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayesha, Azraa, Wallace, Ryan T., Mai, Anthony P., Simpson, Rachel G., Chaya, Craig J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006707/
https://www.ncbi.nlm.nih.gov/pubmed/36915893
http://dx.doi.org/10.1016/j.ajoc.2023.101806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006707/
https://www.ncbi.nlm.nih.gov/pubmed/36915893
http://dx.doi.org/10.1016/j.ajoc.2023.101806

Ejemplares similares